Paper173996
Liver-cell adenomas associated with use of oral contraceptives.
Edmondson HA and 2 others. N Engl J Med, 1976. Cited by 535 papers, by iCite.
Cite this record
ConductScience Library. Liver-cell adenomas associated with use of oral contraceptives. Papers, record 173996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/173996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Contraceptives, Oral | Major topic |
| Liver Neoplasms | Major topic |
| Adult | |
| Ethinyl Estradiol | |
| Female | |
| Humans | |
| Liver | |
| Mestranol | |
| Middle Aged | |
| Risk | |
| Time Factors |
Source PubMed
Cited by120
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 535 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42678415 | Integration of histopathology and molecular features for the classification of benign and malignant hepatocellular neoplasms. | Virchows Arch | 2026 | https://conductscience.org/library/papers/42678415 | PubMed |
| 41364225 | Imaging surveillance outcomes of hepatocellular adenomas: systematic review and meta-analysis. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/41364225 | PubMed |
| 41321651 | Multiple 11C-acetate and 18fludeoxyglucose-avid hepatic tumours in a young woman: primary, secondary, or something else? | J Surg Case Rep | 2025 | https://conductscience.org/library/papers/41321651 | PubMed |
| 41214355 | Hepatic adenoma regression after bariatric surgery: a case series and systematic review. | Surg Endosc | 2026 | https://conductscience.org/library/papers/41214355 | PubMed |
| 41023616 | Gd-EOB-DTPA-enhanced hepatobiliary phase MRI characteristics of inflammatory hepatic adenoma. | BMC Med Imaging | 2025 | https://conductscience.org/library/papers/41023616 | PubMed |
| 40059521 | Insights into hepatocellular adenomas in Asia: molecular subtypes, clinical characteristics, imaging features, and hepatocellular carcinoma risks. | J Liver Cancer | 2025 | https://conductscience.org/library/papers/40059521 | PubMed |
| 38304236 | Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim. | JHEP Rep | 2024 | https://conductscience.org/library/papers/38304236 | PubMed |
| 38133737 | Patient with a novel syndrome with multiple benign hepatic lesions and extrahepatic neoplasms. | Clin J Gastroenterol | 2024 | https://conductscience.org/library/papers/38133737 | PubMed |
| 37872280 | Integrated genotype-phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas. | Virchows Arch | 2024 | https://conductscience.org/library/papers/37872280 | PubMed |
| 37798924 | [Contrast-enhanced ultrasound (CEUS) for characterisation of focal liver lesions]. | Z Gastroenterol | 2024 | https://conductscience.org/library/papers/37798924 | PubMed |
| 37602100 | A Case Report on a Giant Hepatic Inflammatory Adenoma in a Young Female That Presented as Spontaneous Intrahepatic Hematoma. | Cureus | 2023 | https://conductscience.org/library/papers/37602100 | PubMed |
| 36640247 | β-Catenin-activated inflammatory hepatocellular adenoma with pigmentation and atypical features: a case report. | Clin J Gastroenterol | 2023 | https://conductscience.org/library/papers/36640247 | PubMed |
| 36476331 | Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study. | Contraception | 2023 | https://conductscience.org/library/papers/36476331 | PubMed |
| 36097448 | Analysis of Adverse Events and Medical Errors in Long-Term Hormone Treatments for Endometriosis: A Study Based on the US Food and Drug Administration Event Reporting System. | Int J Womens Health | 2022 | https://conductscience.org/library/papers/36097448 | PubMed |
| 35835851 | Benign liver tumours: understanding molecular physiology to adapt clinical management. | Nat Rev Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35835851 | PubMed |
| 35811762 | High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia. | JHEP Rep | 2022 | https://conductscience.org/library/papers/35811762 | PubMed |
| 35168973 | KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35168973 | PubMed |
| 34376442 | Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis. | BMJ Open | 2021 | https://conductscience.org/library/papers/34376442 | PubMed |
| 34362758 | Scoping review of clinical practice guidelines on the management of benign liver tumours. | BMJ Open Gastroenterol | 2021 | https://conductscience.org/library/papers/34362758 | PubMed |
| 33588783 | HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. | BMC Med Imaging | 2021 | https://conductscience.org/library/papers/33588783 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/173996
GET https://conductscience.org/api/papers/v1/173996/cited_by?page=2